Real-World Pharmacokinetics-Pharmacodynamics and Pharmacogenomic Analysis of Tofacitinib, an Oral Janus Kinase Inhibitor, in Patients with Active Ulcerative Colitis
Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics · 2026 · 57 (3) · 30-34
DOI: 10.3999/jscpt.57.3_30 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics, 2026. Verfasst von Masahide FUKUDO. Die Arbeit nennt 13 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
FUKUDO, M. (2026). Real-World Pharmacokinetics-Pharmacodynamics and Pharmacogenomic Analysis of Tofacitinib, an Oral Janus Kinase Inhibitor, in Patients with Active Ulcerative Colitis. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics, 57(3), 30-34. https://doi.org/10.3999/jscpt.57.3_30
Vancouver
FUKUDO M. Real-World Pharmacokinetics-Pharmacodynamics and Pharmacogenomic Analysis of Tofacitinib, an Oral Janus Kinase Inhibitor, in Patients with Active Ulcerative Colitis. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 2026;57(3):30-34. doi:10.3999/jscpt.57.3_30
BibTeX
@article{FUKUDO2026,
author = {FUKUDO, Masahide},
title = {Real-World Pharmacokinetics-Pharmacodynamics and Pharmacogenomic Analysis of Tofacitinib, an Oral Janus Kinase Inhibitor, in Patients with Active Ulcerative Colitis},
journal = {Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics},
year = {2026},
volume = {57},
number = {3},
pages = {30--34},
doi = {10.3999/jscpt.57.3_30}
}
EUVIMED